Skip to main
SABS

SAB Biotherapeutics (SABS)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy SAB Biotherapeutics (SABS) Stock

About SAB Biotherapeutics (SABS)

Big Cypress Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on November 12, 2020 and is headquartered in Miami Beach, FL.
Market cap$357.58M
Yesterday's volume535
Revenue (TTM)
Avg. daily volume666.01K
EBITDA (TTM)-$68.71M
Open$3.86
Price / earnings ratio-2.37x
Yesterday's range$3.84 - $3.93
Debt / equity0.02x
52 week range$1.85 - $5.15
5 year debt / equity0.11x
Beta (LTM)1.23x
Interest coverage-203.41x
Dividend & yield$0.00 (0.00%)
Current ratio9.22x
Ex-dividend date
Next earnings
Dividend payable date

SAB Biotherapeutics Stock Rating

What analysts recommend for SABS stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 78%
Buy 22%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Aug 27, 2026, the market cap for SABS stock is $357.58M

The current P/E ratio for SABS stock is -2.37

The 52-week high for SABS stock is $5.15. The current SABS stock price $undefined is 100.00% below its 52-week high

The 52-week low for SABS stock is $1.85. The current SABS stock price $undefined has increased 100.00% from its 52-week low

No, the SABS stock does not pay dividends to its shareholders

The target price for SABS stock is $12 based on the average of what a group of analyst think SABS stock could be worth at a future date. This is not a prediction by Public.com

How to buy SABS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in SABS stock

    Navigate to the Explore page. Then, type SABS into the search bar. When you see SABS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased SABS stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

SAB Biotherapeutics Stock Earnings

The value each SABS share was expected to gain vs. the value that each SABS share actually gained.

SAB Biotherapeutics (SABS) reported Q2 2026 earnings per share (EPS) of -$0.28, meeting estimates of -$0.28 by 0.00%. In the same quarter last year, SAB Biotherapeutics's earnings per share (EPS) was -$1.09. SAB Biotherapeutics is expected to release next earnings on , with an earnings per share (EPS) estimate of -$0.27.

Buy SAB Biotherapeutics (SABS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.